U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07570355) titled 'Pterygopalatine Ganglion Stimulation for the Treatment of Geographic Atrophy' on April 07.
Brief Summary: The goal of this clinical trial is to evaluate the feasibility and safety of pterygopalatine ganglion (PPG) stimulation in adults with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
The main questions it aims to answer are:
Is PPG stimulation feasible to implement, as reflected by participant adherence to the intervention and completion of follow-up assessments? Is PPG stimulation safe, as assessed by the incidence of adverse events and clinical ophthalmic examinations? What are the preliminary effe...